Abstract: DNA encoding glycoproteins gD, gI and part of gE from Marek's disease herpesvirus is described. The DNA is useful for probes to detect the DNA in the herpesvirus, for expression to produce the glycoproteins can be used for producing the antibodies which specifically recognize the three glycoprotein antigens, and in the case of the latter two genes, for potential insertion sites for foreign genes. Novel glycoproteins and regulatory sequences are also disclosed.
Type:
Grant
Filed:
March 9, 1992
Date of Patent:
October 12, 1993
Assignee:
Board of Trustees operating Michigan State University
Inventors:
Leland F. Velicer, Peter Brunovskis, Paul M. Coussens
Abstract: DNA encoding glycoproteins gD, gI and part of gE from Marek's disease herpesvirus is described. The DNA is useful for probes to detect the DNA in the herpesvirus, for expression to produce the glycoproteins can be used for producing the antibodies which specifically recognize the three glycoprotein antigens, and in the case of the latter two genes, for potential insertion sites for foreign genes. Novel glycoproteins and regulatory sequences are also disclosed.
Type:
Grant
Filed:
March 4, 1992
Date of Patent:
October 12, 1993
Assignee:
Board of Trustees operating Michigan State University
Inventors:
Leland F. Velicer, Peter Brunovskis, Paul M. Coussens
Abstract: Disclosed is carcinoma orosomucoid-related antigen (CORA), a glycoprotein which has a binding affinity for carcinoembryonic antigen (CEA). This glycoprotein is a marker for carcinoma, and is characterized by having a molecular weight of about 46,000-50,000 daltons on SDS-polyacrylamide gels, an isoelectric point of about 3.0-3.5, a carbohydrate content of about 25-35% by weight, an amino acid sequence defined in the Sequence Listing by SEQ ID NO:1, reactivity with antisera raised thereto, and substantially no reactivity with antisera raised to nonspecific cross-reacting antigen (NCA) or to CEA. Also disclosed is a method for detecting and monitoring carcinoma.
Type:
Grant
Filed:
December 19, 1990
Date of Patent:
August 31, 1993
Assignee:
New England Deaconess Hospital Corporation